The global healthcare industry is set to surpass $3 trillion by 2025, fueled by advancements in pharmaceuticals, diagnostics, medical technology, and digital health. Key accelerators include Direct-to-Consumer (DTC) models, increasing M&A activity, and AI/machine learning integration. With digital health expected to grow at a 13% CAGR—reaching over $750 billion by 2028—telemedicine, wearables, and remote monitoring are transforming healthcare delivery.
Watch the Webinar On-Demand: Gain deeper insights from industry leaders and stay ahead of healthcare’s rapid transformation. Click here to access the recorded session.
Frost & Sullivan’s latest Healthcare & Life Sciences webinar identified the top 10 growth opportunities where industry needs, technological advancements, and patient expectations converge, providing a roadmap for clinical and commercial success.
Featured Experts:
- Nitin Naik – Vice President & Global Practice Area Leader, Healthcare & Life Sciences, Frost & Sullivan
- Aarti Siddhesh Chitale – Senior Industry Analyst, Healthcare & Life Sciences, Frost & Sullivan
- Alejandra Maria Parra – Research Analyst, Healthcare & Life Sciences, Frost & Sullivan
- Chinmaya Rath – Strategic Advisor, Pharma Solutions, Cellworks
- Brian Yeh – Vice President, Customer Strategy, League Health
- Sandeep Pulim – Strategic Healthcare Advisor
- Nola E. Masterson – Lead Investor, Portfolia Femtech Fund
Key Takeaways from the Discussion:
- Mental & Behavioral Health Market Growth: Rising awareness and integration into primary care are driving significant expansion. AI-powered diagnostics, digital therapeutics, and self-management tools enhance patient care and engagement.
- Women’s Mental Health Focus: Digital health solutions are addressing perinatal depression and hormonal mood disorders, ensuring comprehensive, lifelong mental health support for women.
- Generative AI in Hospital Workflows: AI-driven tools are optimizing hospital operations, resource allocation, financial workflow automation, and home care management through digital twin-powered decision support.
- Key Players Driving Innovation: Leading companies like ViewMind (AI for cognitive health), Headway (therapy access platform), AKASA (AI for revenue cycle management), and GE Healthcare (real-time tracking) are revolutionizing mental health services and hospital automation.
- Potential Policy Shifts Under a Trump Administration: Private healthcare expansion, AI-driven innovation, and Medicare Advantage growth present opportunities, but regulatory uncertainty, fragmented AI oversight, and economic challenges such as tariffs could impact technology development.
“Leadership teams (C-suites) must strategically the AI transformation journey, prioritizing initiatives that drive enterprise-wide innovation and measurable revenue growth. We anticipate a rapid acceleration of AI adoption across the healthcare and life science industry, unlocking significant opportunities for advancement and value creation.”
Nitin Naik, Vice President & Global Practice Area Leader, Healthcare & Life Sciences, Frost & Sullivan
“Leadership teams (C-suites) must strategically the AI transformation journey, prioritizing initiatives that drive enterprise-wide innovation and measurable revenue growth. We anticipate a rapid acceleration of AI adoption across the healthcare and life science industry, unlocking significant opportunities for advancement and value creation.”Is your organization ready to leverage AI-driven strategies and emerging tech partnerships for healthcare success?
As the industry evolves, targeted use cases and collaborative efforts will be crucial for maximizing value. Healthcare organizations that embrace these trends will be well-positioned to enhance patient outcomes, optimize operations, and stay ahead of the competition.
